Cognitive impairment and risk of future stroke: A systematic review and meta-analysis

CMAJ

Volumn 186, Issue 14, 2014, Pages E536-E546

  Lee, Meng ^a   Saver, Jeffrey L ^b   Hong, Keun Sik ^c   Wu, Yi Ling ^a   Liu, Hsing Cheng ^d   Rao, Neal M ^b   Ovbiagele, Bruce ^e  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Inje University   (South Korea)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DSM-III; GENDER; HUMAN; HYPERTENSION; MINI MENTAL STATE EXAMINATION; OBESITY; OUTCOME ASSESSMENT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; COMPLICATION; META ANALYSIS; MILD COGNITIVE IMPAIRMENT; RISK FACTOR; STROKE;

HUMANS; MILD COGNITIVE IMPAIRMENT; RISK FACTORS; STROKE;

EID: 84907666814     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.140147     Document Type: Article

References (59)

1. Donnan GA, Fisher M, Macleod M, et al. Stroke. Lancet 2008;371:1612-1623.
2. Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006;371: 345-50.
3. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke - Canadian Stroke Network vascular cognitive impairment harmonization standards [published erratum in Stroke 2007;38:1118]. Stroke 2006;37:2220-2241.
4. Ovbiagele B, Goldstein LB, Higashida RT, et al. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke 2013;44:2361-75.
5. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989;262:2551-2556.
6. Kalaria RN. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease. Neurobiol Aging 2009;30:1512-1514.
7. Polidori MC, Pientka L, Mecocci P. A review of the major vascular risk factors related to Alzheimer's disease. J Alzheimers Dis 2012;32:521-530.
8. Dregan A, Wolfe CD, Gulliford MC. Does the influence of stroke on dementia vary by different levels of prestroke cognitive functioning? A cohort study. Stroke 2013;44:3445-51.
9. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
10. Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011;306:1241-1249.
11. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
12. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-560.
13. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions: Oxford (UK): Cochrane Collaboration; 2008.
14. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
15. Lee M, Saver JL, Chang KH, et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010;341:c4249.
16. Dementia: supporting people with dementia and their careers in health and social care [clinical guideline]. London (UK): NICE; 2006. Available: http://guidance.nice.org.uk/CG42 (accessed 2013 Nov. 6).
17. Imfeld P, Bodmer M, Schuerch M, et al. Risk of incident stroke in patients with Alzheimer disease or vascular dementia. Neurology 2013;81:910-9.
18. de Moraes SA, Szklo M, Tilling K, et al. Cognitive functioning as a predictor of ischemic stroke incidence. Epidemiology 2003;14:673-9.
19. Chi NF, Chien LN, Ku HL, et al. Alzheimer disease and risk of stroke: a population-based cohort study. Neurology 2013;80:705-711.
20. Clarke PJ, Blount V, Colantonio A. Cognitive impairment predicts fatal incident stroke: findings from a national sample of older adults. J Am Geriatr Soc 2011;59:1490-6.
21. de Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009;52:2328-2336.
22. Ferrucci L, Guralnik JM, Salive ME, et al. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 1996;44:237-241.
23. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 1996;312:608-611.
24. Glymour MM, Maselko J, Gilman SE, et al. Depressive symptoms predict incident stroke independently of memory impairments. Neurology 2010;75:2063-70.
25. Liebetrau M, Steen B, Skoog I. Depression as a risk factor for the incidence of first-ever stroke in 85-year-olds. Stroke 2008;? 39:?1960-5.
26. O'Donnell M, Teo K, Gao P, et al. Cognitive impairment and risk of cardiovascular events and mortality. Eur Heart J 2012;33:1777-1786.
27. Ostir GV, Raji MA, Ottenbacher KJ, et al. Cognitive function and incidence of stroke in older Mexican Americans. J Gerontol A Biol Sci Med Sci 2003;58:531-535.
28. Pettigrew LC, Thomas N, Howard VJ, et al. Low mini-mental status predicts mortality in asymptomatic carotid arterial stenosis. Asymptomatic Carotid Atherosclerosis Study investigators. Neurology 2000;55:30-34.
29. Reitz C, Bos MJ, Hofman A, et al. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke 2008;39:36-41.
30. Sabayan B, Gussekloo J, de Ruijter W, et al. Framingham stroke risk score and cognitive impairment for predicting firsttime stroke in the oldest old. Stroke 2013;44:1866-71.
31. Shipley BA, Der G, Taylor MD, et al. Cognition and mortality from the major causes of death: the Health and Lifestyle Survey. J Psychosom Res 2008;65:143-152.
32. Skoog I, Lithell H, Hansson L, et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens 2005;18:1052-9.
33. Weinstein G, Beiser AS, Decarli C, et al. Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study. Stroke 2013;44:2787-2794.
34. Wiberg B, Lind L, Kilander L, et al. Cognitive function and risk of stroke in elderly men. Neurology 2010;74:379-385.
35. Zhu L, Fratiglioni L, Guo Z, et al. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology 2000;54:2103-7.
36. Kuller LH, Shemanski L, Manolio T, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke 1998;29:388-98.
37. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222.
38. Luchsinger JA, Brickman AM, Reitz C, et al. Subclinical cerebrovascular disease in mild cognitive impairment. Neurology 2009;73:450-6.
39. Sabayan B, Jansen S, Oleksik AM, et al. Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies. Ageing Res Rev 2012;11:271-277.
40. van Norden AG, van Uden IW, de Laat KF, et al. Cerebral microbleeds are related to subjective cognitive failures: the RUN DMC study. Neurobiol Aging 2013;34:2225-30.
41. Park JH, Seo SW, Kim C, et al. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol 2013;73:584-93.
42. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-2022.
43. Kuo HK, Yen CJ, Chang CH, et al. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005;4:371-80.
44. Feng L, Isaac V, Sim S, et al. Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults. Am J Geriatr Psychiatry 2013;?21:? 164-72.
45. Reis JP, Launer LJ, Terry JG, et al. Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: The CARDIA study. Atherosclerosis 2013;231:72-77.
46. Hermann DM, Gronewold J, Lehmann N, et al. Coronary artery calcification is an independent stroke predictor in the general population. Stroke 2013;44:1008-13.
47. Sabayan B, Wijsman LW, Foster-Dingley JC, et al. Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study. BMJ 2013;?347:? f4600.
48. Hashimoto T, Kikuya M, Ohkubo T, et al. Home blood pressure level, blood pressure variability, smoking, and stroke risk in Japanese men: the Ohasama study. Am J Hypertens 2012;?25:? 883-91.
49. Rothwell PM, Howard SC, Dolan E, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010;9:469-80.
50. Kim G, Kim H, Kim KN, et al. Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey. J Alzheimers Dis 2013;33:853-62.
51. Wu MS, Lan TH, Chen CM, et al. Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan. BMC Public Health 2011;11:22.
52. Campbell NL, Boustani MA, Skopelja EN, et al. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother 2012;? 10:165-77.
53. Song X, Mitnitski A, Rockwood K. Nontraditional risk factors combine to predict Alzheimer disease and dementia. Neurology 2011;77:227-34.
54. Richard E, Reitz C, Honig LH, et al. Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol 2013;70:374-382.
55. Jin YP, Ostbye T, Feightner JW, et al. Joint effect of stroke and APOE 4 on dementia risk: the Canadian Study of Health and Aging. Neurology 2008;70:9-16.
56. Mai LM, Oczkowski W, Mackenzie G, et al. Screening for cognitive impairment in a stroke prevention clinic using the MoCA. Can J Neurol Sci 2013;40:192-7.
57. Godefroy O, Fickl A, Roussel M, et al. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke 2011;42:1712-6.
58. Tanskanen M, Kalaria RN, Notkola IL, et al. Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old. Curr Alzheimer Res 2013;10:1090-7.
59. Gurol ME, Dierksen G, Betensky R, et al. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology 2012;79:320-6.